Skip to main content

ADVERTISEMENT

Stephane G. Carlier, MD, PhD

08/01/2008
In-stent restenosis is the result of neointimal hyperplasia that, by intravascular ultrasound (IVUS) imaging, typically has a homogeneous, echoreflective appearance. Histological and immunohistochemical analyses of “typical” in-stent...
In-stent restenosis is the result of neointimal hyperplasia that, by intravascular ultrasound (IVUS) imaging, typically has a homogeneous, echoreflective appearance. Histological and immunohistochemical analyses of “typical” in-stent...
In-stent restenosis is the...
08/01/2008
Journal of Invasive Cardiology
06/19/2008
Bifurcation lesions are common and have been reported to make up approximately 23% of currently treated lesions. In a series capturing ‘real world’ experience with drug-eluting stents, bifurcation lesions were associated with a greater than...
Bifurcation lesions are common and have been reported to make up approximately 23% of currently treated lesions. In a series capturing ‘real world’ experience with drug-eluting stents, bifurcation lesions were associated with a greater than...
Bifurcation lesions are common...
06/19/2008
Cath Lab Digest
Feature
06/19/2008
Bifurcation lesions are common and have been reported to make up approximately 23% of currently treated lesions. In a series capturing ‘real world’ experience with drug-eluting stents, bifurcation lesions were associated with a greater than...
Bifurcation lesions are common and have been reported to make up approximately 23% of currently treated lesions. In a series capturing ‘real world’ experience with drug-eluting stents, bifurcation lesions were associated with a greater than...
Bifurcation lesions are common...
06/19/2008
Cath Lab Digest
Original Contribution
08/01/2008
Sirolimus-eluting and paclitaxel-eluting stents decrease neointimal hyperplasia leading to a reduction, but not elimination, of in-stent restenosis.1–4 Because sirolimus and paclitaxel decrease neointimal hyperplasia, restenosis is dependent...
Sirolimus-eluting and paclitaxel-eluting stents decrease neointimal hyperplasia leading to a reduction, but not elimination, of in-stent restenosis.1–4 Because sirolimus and paclitaxel decrease neointimal hyperplasia, restenosis is dependent...
Sirolimus-eluting and...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/07/2023
Overall, 9 patients underwent a percutaneous coronary intervention (PCI) targeting a chronic total occlusion (CTO) between June 2021 and January 2022 at a single Belgian center using the virtual proctoring approach. For this assessment, the...
Overall, 9 patients underwent a percutaneous coronary intervention (PCI) targeting a chronic total occlusion (CTO) between June 2021 and January 2022 at a single Belgian center using the virtual proctoring approach. For this assessment, the...
Overall, 9 patients underwent a...
08/07/2023
Journal of Invasive Cardiology